Simultaneous TAVR and TMVR Sachin S Goel MD, Waleed Alharbi MD, - - PowerPoint PPT Presentation

simultaneous tavr and tmvr
SMART_READER_LITE
LIVE PREVIEW

Simultaneous TAVR and TMVR Sachin S Goel MD, Waleed Alharbi MD, - - PowerPoint PPT Presentation

Simultaneous TAVR and TMVR Sachin S Goel MD, Waleed Alharbi MD, Vincent Zuck MD, Nilesh Goswami MD Structural Heart Program, Prairie Heart Institute St Johns Hospital, Springfield IL, USA June 21, 2018 Disclosure Statement of f Financial In


slide-1
SLIDE 1

Simultaneous TAVR and TMVR

Sachin S Goel MD, Waleed Alharbi MD, Vincent Zuck MD, Nilesh Goswami MD Structural Heart Program, Prairie Heart Institute St John’s Hospital, Springfield IL, USA June 21, 2018

slide-2
SLIDE 2

Disclosure Statement of f Financial In Interest

I, [Sachin Goel MD], DO NOT have a financial interest/arrangement or affiliation with one or more

  • rganizations that could be perceived as a real or

apparent conflict of interest in the context of the subject of this presentation.

slide-3
SLIDE 3

VR VR – 75 75 yr yr old Female, 162.6 .6 cm, , 75.3 .3 Kg

  • NYHA III-IV CHF, Admitted with NSTEMI, Acute CHF exacerbation, and

hypotension with dialysis

  • Paroxysmal AFIB- Coumadin
  • CAD with h/o PCI
  • ESRD on dialysis
  • h/o embolic CVA
  • Anemia with GI bleed (AV malformations)
  • Diabetes- Insulin
  • Hypertension
  • Hyperlipidemia
  • Aortic Stenosis- low flow low gradient with SVI of 16.2
  • Mitral Stenosis with mean gradient of 10 and moderately severe MR
  • STS: 26.82
  • Surgical risk: high to prohibitive risk
slide-4
SLIDE 4
slide-5
SLIDE 5
slide-6
SLIDE 6

Vmax 3.7 m/sec Mean AV gradient 32 mm Hg Mean mitral gradient 10 mm Hg

slide-7
SLIDE 7

Annular Measurement

Annulus by CT (Date) Measure Annular Perimeter 71.9 Annular Area 3.93 Valves #23 S3 (+3.3%) #26 Evolut R/PRO Comment:

slide-8
SLIDE 8

Aortic Complex

slide-9
SLIDE 9

Mitral Measurements

#29 S3

slide-10
SLIDE 10

Right Heart Catheterization and Coronary Angiogram

RA: 24 mm Hg RV: 79/21 mm Hg PA: 78/40 (55) mm Hg PCWP: 40 mm Hg LV: 138/30 mm Hg Aorta: 100/62 mm Hg Low cardiac output

slide-11
SLIDE 11

Access

slide-12
SLIDE 12
slide-13
SLIDE 13

STS: 26.82 Echocardiography: AVA: 0.61 AV velocity: 2.79 Commercial: Edwards Access: TF RIGHT TAVR/ mitral position transseptal Planned Valve Size: Double valve procedure with a #23 Edwards S3 in the aortic position with the sentinel device followed by a #29 Edwards S3 in the mitral position CT Annular Measurements: Aortic Area: 3.93, Perimeter: 71.9 Mitral: 5.54 sq cm, Avg Dia 27 mm Key Risk Contributors: multiple comorbidities, ESRD on hemodialysis, severe AS and MS, moderately depressed right ventricular function, and multiple CVA’s Date Procedure Planned: 3/22/18

TAVR/TMVR Summary

Echo: TEE Anesthesia: General Cath LCX Roto PCI, LAD PCI

slide-14
SLIDE 14
slide-15
SLIDE 15
slide-16
SLIDE 16
slide-17
SLIDE 17
slide-18
SLIDE 18

1 month follow up Echocardiogram

slide-19
SLIDE 19

Conclusion

  • Successful case of TAVR and TMVR with balloon-expandable aortic

valves in extreme surgical risk patient with severe AS and severe MAC with mitral stenosis and mitral regurgitation